Stargardt’s or macular dystrophy leads to the deterioration of the macula. Conventional interventions such as pharmacotherapy and the use of low-vision devices have only provided paltry relief and therefore emphasize the need for improved treatments.
This is the reason why there is so much hope and expectations from stem cell therapy.
Combined with proteolytic enzyme therapy stem cell administration has been identified as a revolutionary treatment regime for stargardt’s or macular dystrophy.
Retinal stem cells possess an innate capacity to differentiate into a number of cell phenotypes such as retinal cells that are degenerated or otherwise harmed in stargardt’s or macular dystrophy. Stem cells are intended to replace the dead cells in the retina with normal stem cells, and in this way to stop or even perhaps reverse the progression of vision loss.
Innovative Stem Cell Types
Several types of stem cells are being explored for stargardt’s or macular dystrophy treatment Embryonic Stem Cells, Induced Pluripotent Stem Cells (iPSCs) and Adult Stem Cells.
Advancements in Delivery Systems
Delivery of stem cells to the retina is also important to improve the chances of the best possible treatment. Scientists are working on sophisticated conduits for stem cell delivery, so that these cells may translocate to the desired locations. These are very important in enhancing the efficacy of stem cell treatments as they offer the highest potential for healing.
Choosing the Right Clinic
Choose clinics that can demonstrate efficiency in performing stem cell treatments, apply the best specialists, and have all the high-tech equipment. You can thus make a well-informed decision of where to seek the treatment.
Understanding macular dystrophy and stargadt’s disease
Stargardt’s or macular dystrophy are two inherited diseases which affect vision although they are different in the identification and mode of inheritance. Stargardt’s or macular dystrophy disease that occurs in childhood or early adulthood is a type of macular degeneration which is specific to the macula where the central vision is formed. This is often as a result of genetic abnormality in the ABCA4 gene, causing the progressive build up of toxic substances which damage the retina and the vision.
Macular dystrophy can be referred to a group of hereditary disease of the macula that cause gradual loss of vision. These conditions differ in the manner and the degree in which they are manifested and in their genetic basis. Stargardt’s or macular dystrophy cause the same disability of central vision loss, but they are caused by different gene mutations and are progressive in different ways.
Why Choose StemCellCure
Welcome to Stem Cell Treatment in Australia where cutting-edge stem cell therapies are offered for a new vision of vision care. Our team of specialists uses high technology and individual approaches to provide hope to all patients with stargardt’s or macular dystrophy. In this way, the patient has access to a number of innovative technologies and, at the same time, to the essential treatments for stargardt’s or macular dystrophy. Learn how we can assist you in finding your vision back and improve your quality of life by visiting StemCellCure today.